We are relentlessly pursuing the innovations of tomorrow with our broad and diverse pipeline of potential first or best-in-class investigational medicines designed to treat a range of diseases across our focus areas of neurology, cardiology and rare diseases.
Ionis pipeline information updated as of November 6, 2024